HUP0300990D0 - Synergistic combination for the prophylaxis and treatment of diabetes - Google Patents
Synergistic combination for the prophylaxis and treatment of diabetesInfo
- Publication number
- HUP0300990D0 HUP0300990D0 HU0300990A HUP0300990A HUP0300990D0 HU P0300990 D0 HUP0300990 D0 HU P0300990D0 HU 0300990 A HU0300990 A HU 0300990A HU P0300990 A HUP0300990 A HU P0300990A HU P0300990 D0 HUP0300990 D0 HU P0300990D0
- Authority
- HU
- Hungary
- Prior art keywords
- prophylaxis
- diabetes
- treatment
- synergistic combination
- synergistic
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 239000011885 synergistic combination Substances 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0300990A HUP0300990A2 (en) | 2003-04-15 | 2003-04-15 | Synergistic combination for the prophylaxis and treatment of diabetes |
JP2006506248A JP2006523668A (en) | 2003-04-15 | 2004-04-14 | Synergistic pharmaceutical combination containing cicletanine for the prevention or treatment of diabetes |
YUP-2005/0776A RS20050776A (en) | 2003-04-15 | 2004-04-14 | A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment diabetes |
EP04727331A EP1648453A1 (en) | 2003-04-15 | 2004-04-14 | A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes |
PCT/HU2004/000037 WO2004091612A1 (en) | 2003-04-15 | 2004-04-14 | A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes |
CA002522126A CA2522126A1 (en) | 2003-04-15 | 2004-04-14 | A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0300990A HUP0300990A2 (en) | 2003-04-15 | 2003-04-15 | Synergistic combination for the prophylaxis and treatment of diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300990D0 true HUP0300990D0 (en) | 2003-06-28 |
HUP0300990A2 HUP0300990A2 (en) | 2005-05-30 |
Family
ID=90001685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300990A HUP0300990A2 (en) | 2003-04-15 | 2003-04-15 | Synergistic combination for the prophylaxis and treatment of diabetes |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1648453A1 (en) |
JP (1) | JP2006523668A (en) |
CA (1) | CA2522126A1 (en) |
HU (1) | HUP0300990A2 (en) |
RS (1) | RS20050776A (en) |
WO (1) | WO2004091612A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050113314A1 (en) * | 2003-08-29 | 2005-05-26 | Fong Benson M. | Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
US20050054731A1 (en) * | 2003-09-08 | 2005-03-10 | Franco Folli | Multi-system therapy for diabetes, the metabolic syndrome and obesity |
CA2546793A1 (en) * | 2003-12-16 | 2005-06-30 | Novartis Ag | Use of stating for the treatment of metabolic syndrome |
EP1804795A4 (en) * | 2004-09-22 | 2007-11-07 | Cornett Glen | Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
US20080096915A1 (en) * | 2005-01-13 | 2008-04-24 | Greenberg Traurig LLP | Compositions for the treatment of metabolic disorders |
KR101701943B1 (en) | 2009-11-13 | 2017-02-02 | 도레이 카부시키가이샤 | Therapeutic or prophylactic agent for diabetes |
ES2869423T3 (en) | 2011-08-08 | 2021-10-25 | Immunomet Therapeutics Inc | N1-cyclic amine-N5-substituted phenylbiguanide derivatives and pharmaceutical composition comprising the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN156817B (en) * | 1981-02-10 | 1985-11-09 | Scras |
-
2003
- 2003-04-15 HU HU0300990A patent/HUP0300990A2/en unknown
-
2004
- 2004-04-14 RS YUP-2005/0776A patent/RS20050776A/en unknown
- 2004-04-14 CA CA002522126A patent/CA2522126A1/en not_active Abandoned
- 2004-04-14 WO PCT/HU2004/000037 patent/WO2004091612A1/en not_active Application Discontinuation
- 2004-04-14 EP EP04727331A patent/EP1648453A1/en not_active Withdrawn
- 2004-04-14 JP JP2006506248A patent/JP2006523668A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2004091612A1 (en) | 2004-10-28 |
JP2006523668A (en) | 2006-10-19 |
RS20050776A (en) | 2007-11-15 |
CA2522126A1 (en) | 2004-10-28 |
EP1648453A1 (en) | 2006-04-26 |
HUP0300990A2 (en) | 2005-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1152474A1 (en) | Methods and compositions for the prevention and treatment of sepsis | |
EP1543034A4 (en) | Treatment and prophylaxis with 4-1bb-binding agents | |
ZA200709727B (en) | Compounds and methods for the treatment of prevention of flavivirus infections | |
HUS2200036I1 (en) | Use of dihydroimidazolones for the treatment of dogs | |
PL1732575T3 (en) | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions | |
GB2418025B (en) | Device for the prevention or treatment of ulcers | |
AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
GB0326486D0 (en) | Combination treatment | |
IL187405A0 (en) | Methods and compositions for the treatment of pain | |
IL178903A0 (en) | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions | |
HK1082923A1 (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency | |
HUP0300990D0 (en) | Synergistic combination for the prophylaxis and treatment of diabetes | |
PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
GB2388027B (en) | Use of palatinose for the treatment of mental stress | |
ZA200608918B (en) | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions | |
EP1671648A4 (en) | Prevention and treatment for gvhd | |
EP1660007A4 (en) | Compositions for diabetes treatment and prophylaxis | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
AU2003291461A8 (en) | Compositions for diabetes treatment and prophylaxis | |
EP1648469A4 (en) | Antiglucocorticoids for the treatment of catatonia | |
GB2401044B (en) | A composition for use in the treatment or prophylaxis of a skin condition in a subject | |
AU2003240174A8 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
ZA200710476B (en) | Methods and compositions for the treatment of pain | |
IL162492A0 (en) | Use of alkylphosphocholines for the preventative treatment of protozoandiseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |